제품 > 재조합 단백질

Biotinylated Recombinant Human MS4A1/CD20 Protein (RP00584BLQ)

Datasheet

Overview

Product nameBiotinylated Recombinant Human MS4A1/CD20 Protein
Catalog No.RP00584BLQ
DescriptionBiotinylated Recombinant Human MS4A1/CD20 Protein is produced by E. coli expression system. The target protein is expressed with sequence (Ile141-Ser188) of Human MS4A1/CD20 (Accession #P11836-1) fused with a C-His&Avi tag at the C-terminus.
Purity> 95% by SDS-PAGE
Endotoxin< 1 EU/μg of the protein by LAL method
FormulationSupplied as 0.22 μm filtered solution in 20 mM PB, 10% Glycerol (pH 7.0).
SpeciesHuman
Calculated MW16.8 kDa
B-lymphocyte antigen CD20 or CD20 is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R , CD117) and progressively increasing in concentration until maturity.CD20 is the target of the monoclonal antibodies rituximab, ocrelizumab, obinutuzumab, ofatumumab, ibritumomab tiuxetan, tositumomab, and ublituximab, which are all active agents in the treatment of all B cell lymphomas, leukemias, and B cell-mediated autoimmune diseases.
SynonymMS4A1; CD20; MS4A-1; B1; Bp35; CD20 receptor; CD20S7; CVID5; LEU-16; Ly-44; MS4A2; S7
Expression HostE. coli
TagC-His&Avi
Swiss-Prot
Gene ID
StorageStore at -70℃. This product is stable at ≤ -70℃ for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles.

* For research use only. Not for therapeutic or diagnostic purposes.

항체 (11)

재조합 단백질 (2)

용량을 선택하세요
문의하기